

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aggressive behavior (GO:0002118) | 8.45046760 |
| 2 | hyperosmotic salinity response (GO:0042538) | 7.26044830 |
| 3 | female mating behavior (GO:0060180) | 7.12919992 |
| 4 | regulation of female receptivity (GO:0045924) | 7.01414893 |
| 5 | seminiferous tubule development (GO:0072520) | 6.98486980 |
| 6 | negative regulation of B cell apoptotic process (GO:0002903) | 5.94071088 |
| 7 | regulation of transmission of nerve impulse (GO:0051969) | 5.69808513 |
| 8 | mucosal-associated lymphoid tissue development (GO:0048537) | 5.67425670 |
| 9 | Peyers patch development (GO:0048541) | 5.67425670 |
| 10 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.58409968 |
| 11 | grooming behavior (GO:0007625) | 5.43650160 |
| 12 | purine deoxyribonucleotide catabolic process (GO:0009155) | 5.38327343 |
| 13 | purine nucleotide salvage (GO:0032261) | 5.29052323 |
| 14 | mature B cell differentiation involved in immune response (GO:0002313) | 5.14458620 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 4.81133636 |
| 16 | positive regulation of amino acid transport (GO:0051957) | 4.78581146 |
| 17 | definitive hemopoiesis (GO:0060216) | 4.66470534 |
| 18 | maternal behavior (GO:0042711) | 4.53728379 |
| 19 | positive regulation of systemic arterial blood pressure (GO:0003084) | 4.43473041 |
| 20 | deoxyribonucleotide catabolic process (GO:0009264) | 4.32075378 |
| 21 | cellular hyperosmotic response (GO:0071474) | 4.16537591 |
| 22 | regulation of B cell apoptotic process (GO:0002902) | 4.15721856 |
| 23 | hyperosmotic response (GO:0006972) | 4.10539009 |
| 24 | parental behavior (GO:0060746) | 4.06750992 |
| 25 | deoxyribose phosphate catabolic process (GO:0046386) | 4.05268930 |
| 26 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.02478324 |
| 27 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.86599777 |
| 28 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.86488154 |
| 29 | protein kinase C signaling (GO:0070528) | 3.84141166 |
| 30 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.73823476 |
| 31 | nucleotide salvage (GO:0043173) | 3.70119145 |
| 32 | response to interferon-beta (GO:0035456) | 3.65643991 |
| 33 | mature B cell differentiation (GO:0002335) | 3.65298798 |
| 34 | regulation of glutamate secretion (GO:0014048) | 3.63553952 |
| 35 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.62215960 |
| 36 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.54537146 |
| 37 | regulation of B cell differentiation (GO:0045577) | 3.46708342 |
| 38 | positive regulation of prostaglandin secretion (GO:0032308) | 3.45280222 |
| 39 | regulation of penile erection (GO:0060405) | 3.43682426 |
| 40 | endothelium development (GO:0003158) | 3.42272276 |
| 41 | regulation of respiratory burst (GO:0060263) | 3.38145820 |
| 42 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.37589608 |
| 43 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.36114983 |
| 44 | cellular response to interferon-beta (GO:0035458) | 3.34441987 |
| 45 | drinking behavior (GO:0042756) | 3.32903883 |
| 46 | base-excision repair, AP site formation (GO:0006285) | 3.31724146 |
| 47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.31606100 |
| 48 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.25978883 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.25600506 |
| 50 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.25347856 |
| 51 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.25347856 |
| 52 | negative regulation of neurological system process (GO:0031645) | 3.23149290 |
| 53 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.22549984 |
| 54 | regulation of mitochondrial translation (GO:0070129) | 3.21920416 |
| 55 | sodium-independent organic anion transport (GO:0043252) | 3.21768058 |
| 56 | cellular response to exogenous dsRNA (GO:0071360) | 3.17512874 |
| 57 | immunoglobulin mediated immune response (GO:0016064) | 3.17190555 |
| 58 | positive regulation of organic acid transport (GO:0032892) | 3.13666552 |
| 59 | autophagic vacuole fusion (GO:0000046) | 3.13216361 |
| 60 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.13193277 |
| 61 | purine-containing compound salvage (GO:0043101) | 3.12425800 |
| 62 | deoxyribose phosphate metabolic process (GO:0019692) | 3.11441110 |
| 63 | pinocytosis (GO:0006907) | 3.02819553 |
| 64 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.02511250 |
| 65 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.00065563 |
| 66 | short-chain fatty acid metabolic process (GO:0046459) | 2.98883147 |
| 67 | mitochondrial calcium ion transport (GO:0006851) | 2.98077487 |
| 68 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91826391 |
| 69 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.88158201 |
| 70 | prostanoid biosynthetic process (GO:0046457) | 2.87576204 |
| 71 | prostaglandin biosynthetic process (GO:0001516) | 2.87576204 |
| 72 | histamine secretion (GO:0001821) | 2.86951335 |
| 73 | negative regulation of necrotic cell death (GO:0060547) | 2.84343588 |
| 74 | daunorubicin metabolic process (GO:0044597) | 2.84261756 |
| 75 | polyketide metabolic process (GO:0030638) | 2.84261756 |
| 76 | doxorubicin metabolic process (GO:0044598) | 2.84261756 |
| 77 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80421558 |
| 78 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.77269400 |
| 79 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.74153632 |
| 80 | deoxyribonucleotide metabolic process (GO:0009262) | 2.73075375 |
| 81 | regulation of prostaglandin secretion (GO:0032306) | 2.72611785 |
| 82 | ribosomal small subunit assembly (GO:0000028) | 2.70093227 |
| 83 | regulation of excretion (GO:0044062) | 2.69489531 |
| 84 | negative regulation of digestive system process (GO:0060457) | 2.63258684 |
| 85 | dosage compensation (GO:0007549) | 2.60222609 |
| 86 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.59981114 |
| 87 | DNA deamination (GO:0045006) | 2.59094240 |
| 88 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.58033340 |
| 89 | B cell mediated immunity (GO:0019724) | 2.57839434 |
| 90 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.56669262 |
| 91 | actin nucleation (GO:0045010) | 2.55660399 |
| 92 | positive regulation of antigen processing and presentation (GO:0002579) | 2.55071103 |
| 93 | regulation of icosanoid secretion (GO:0032303) | 2.54326151 |
| 94 | cell differentiation involved in metanephros development (GO:0072202) | 2.54245104 |
| 95 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.54219666 |
| 96 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.54219666 |
| 97 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.53032492 |
| 98 | metallo-sulfur cluster assembly (GO:0031163) | 2.52271388 |
| 99 | iron-sulfur cluster assembly (GO:0016226) | 2.52271388 |
| 100 | protein complex biogenesis (GO:0070271) | 2.50677999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.07230929 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.87889661 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.23480440 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.17109456 |
| 5 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.04425238 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.96229161 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.87273079 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.85740033 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.81359291 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22430692 |
| 11 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19191882 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.18585073 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16271369 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.12182003 |
| 15 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09573372 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.06792299 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.06510151 |
| 18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.06394733 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02049038 |
| 20 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.01186922 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.99449396 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.95538836 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95382988 |
| 24 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.92487943 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.90910674 |
| 26 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.87101699 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.86708676 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.86072542 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84452957 |
| 30 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.83658628 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.82140249 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.75197556 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72794091 |
| 34 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.70075122 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.69611449 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.69609773 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.69356121 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.57976658 |
| 39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55560375 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54423082 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52429563 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.51711150 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46920322 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46106296 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46055378 |
| 46 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.45908808 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.45587461 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42214242 |
| 49 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.41363168 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.41020873 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37647681 |
| 52 | P68_20966046_ChIP-Seq_HELA_Human | 1.35996982 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.35602076 |
| 54 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.34366855 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34339992 |
| 56 | MYB_26560356_Chip-Seq_TH1_Human | 1.33987501 |
| 57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.33518015 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31780967 |
| 59 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.30014926 |
| 60 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29862793 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.29591701 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29033481 |
| 63 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28825647 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28071344 |
| 65 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.26970627 |
| 66 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.25680512 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25458951 |
| 68 | P300_27268052_Chip-Seq_Bcells_Human | 1.23972936 |
| 69 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.23416648 |
| 70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22431871 |
| 71 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.21898923 |
| 72 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.20208625 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19855600 |
| 74 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.19399333 |
| 75 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.19029890 |
| 76 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.18177905 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17082096 |
| 78 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15954883 |
| 79 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.15111164 |
| 80 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14516935 |
| 81 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14506264 |
| 82 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.14331340 |
| 83 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.13254511 |
| 84 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.13020777 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12567153 |
| 86 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09509751 |
| 87 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09119742 |
| 88 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08955272 |
| 89 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.08467963 |
| 90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08217636 |
| 91 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.05441497 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.05167417 |
| 93 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.04591068 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03804553 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03784382 |
| 96 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03733125 |
| 97 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.02956591 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02881423 |
| 99 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.02176689 |
| 100 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.00911737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 6.50835462 |
| 2 | MP0005645_abnormal_hypothalamus_physiol | 4.93233107 |
| 3 | MP0001545_abnormal_hematopoietic_system | 4.48585451 |
| 4 | MP0005397_hematopoietic_system_phenotyp | 4.48585451 |
| 5 | MP0000465_gastrointestinal_hemorrhage | 4.06607152 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.99885466 |
| 7 | MP0002396_abnormal_hematopoietic_system | 3.13503721 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.01673158 |
| 9 | MP0009697_abnormal_copulation | 2.76401152 |
| 10 | MP0008058_abnormal_DNA_repair | 2.53756416 |
| 11 | MP0008057_abnormal_DNA_replication | 2.06364825 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.03519991 |
| 13 | MP0003436_decreased_susceptibility_to | 2.00330746 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 1.93626802 |
| 15 | MP0002132_abnormal_respiratory_system | 1.92756643 |
| 16 | MP0005025_abnormal_response_to | 1.85086790 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 1.83856582 |
| 18 | MP0002822_catalepsy | 1.76219011 |
| 19 | MP0002234_abnormal_pharynx_morphology | 1.75294666 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.72778708 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 1.61981263 |
| 22 | MP0003718_maternal_effect | 1.58723351 |
| 23 | MP0002398_abnormal_bone_marrow | 1.58699008 |
| 24 | MP0008007_abnormal_cellular_replicative | 1.55876590 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 1.54503196 |
| 26 | MP0009379_abnormal_foot_pigmentation | 1.50489141 |
| 27 | MP0003866_abnormal_defecation | 1.49599505 |
| 28 | MP0006292_abnormal_olfactory_placode | 1.49457677 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.48774143 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.48217914 |
| 31 | MP0002419_abnormal_innate_immunity | 1.48158094 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.48003418 |
| 33 | MP0001819_abnormal_immune_cell | 1.46897343 |
| 34 | MP0003724_increased_susceptibility_to | 1.42953962 |
| 35 | MP0002019_abnormal_tumor_incidence | 1.40206362 |
| 36 | MP0000685_abnormal_immune_system | 1.38492285 |
| 37 | MP0002722_abnormal_immune_system | 1.37438910 |
| 38 | MP0002723_abnormal_immune_serum | 1.36302781 |
| 39 | MP0001881_abnormal_mammary_gland | 1.36233505 |
| 40 | MP0000716_abnormal_immune_system | 1.32800405 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.31521981 |
| 42 | MP0003075_altered_response_to | 1.25726549 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.24974595 |
| 44 | MP0009785_altered_susceptibility_to | 1.24628216 |
| 45 | MP0002405_respiratory_system_inflammati | 1.24055904 |
| 46 | MP0010094_abnormal_chromosome_stability | 1.23194232 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.22820669 |
| 48 | MP0003787_abnormal_imprinting | 1.19989071 |
| 49 | MP0002429_abnormal_blood_cell | 1.19892158 |
| 50 | MP0000681_abnormal_thyroid_gland | 1.19746664 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.17537754 |
| 52 | MP0004147_increased_porphyrin_level | 1.16849443 |
| 53 | MP0009840_abnormal_foam_cell | 1.14858847 |
| 54 | MP0001790_abnormal_immune_system | 1.14030554 |
| 55 | MP0005387_immune_system_phenotype | 1.14030554 |
| 56 | MP0001800_abnormal_humoral_immune | 1.13825493 |
| 57 | MP0005220_abnormal_exocrine_pancreas | 1.13058507 |
| 58 | MP0000490_abnormal_crypts_of | 1.11715224 |
| 59 | MP0001905_abnormal_dopamine_level | 0.98553947 |
| 60 | MP0008469_abnormal_protein_level | 0.96435097 |
| 61 | MP0008872_abnormal_physiological_respon | 0.96205660 |
| 62 | MP0000516_abnormal_urinary_system | 0.96050518 |
| 63 | MP0005367_renal/urinary_system_phenotyp | 0.96050518 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 0.94875636 |
| 65 | MP0003186_abnormal_redox_activity | 0.93967558 |
| 66 | MP0010368_abnormal_lymphatic_system | 0.88852259 |
| 67 | MP0000678_abnormal_parathyroid_gland | 0.88571671 |
| 68 | MP0005646_abnormal_pituitary_gland | 0.87539549 |
| 69 | MP0005266_abnormal_metabolism | 0.85950669 |
| 70 | MP0005165_increased_susceptibility_to | 0.85840754 |
| 71 | MP0003943_abnormal_hepatobiliary_system | 0.85077384 |
| 72 | MP0006276_abnormal_autonomic_nervous | 0.83269532 |
| 73 | MP0000703_abnormal_thymus_morphology | 0.83153582 |
| 74 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80418195 |
| 75 | MP0002653_abnormal_ependyma_morphology | 0.79535801 |
| 76 | MP0000613_abnormal_salivary_gland | 0.78980164 |
| 77 | MP0001845_abnormal_inflammatory_respons | 0.76413545 |
| 78 | MP0005410_abnormal_fertilization | 0.76217576 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 0.74990706 |
| 80 | MP0008873_increased_physiological_sensi | 0.72223198 |
| 81 | MP0001764_abnormal_homeostasis | 0.68936214 |
| 82 | MP0003303_peritoneal_inflammation | 0.68285801 |
| 83 | MP0010155_abnormal_intestine_physiology | 0.67917879 |
| 84 | MP0003252_abnormal_bile_duct | 0.67183390 |
| 85 | MP0009764_decreased_sensitivity_to | 0.66407697 |
| 86 | MP0005535_abnormal_body_temperature | 0.65780864 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.64337515 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.64015811 |
| 89 | MP0001853_heart_inflammation | 0.63995293 |
| 90 | MP0001533_abnormal_skeleton_physiology | 0.63556713 |
| 91 | MP0000313_abnormal_cell_death | 0.63302280 |
| 92 | MP0009763_increased_sensitivity_to | 0.62958806 |
| 93 | MP0008995_early_reproductive_senescence | 0.62168764 |
| 94 | MP0001968_abnormal_touch/_nociception | 0.59313706 |
| 95 | MP0001119_abnormal_female_reproductive | 0.58663539 |
| 96 | MP0003111_abnormal_nucleus_morphology | 0.58498986 |
| 97 | MP0001664_abnormal_digestion | 0.58349898 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.54861159 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.53798438 |
| 100 | MP0004043_abnormal_pH_regulation | 0.53293158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.48854543 |
| 2 | Agammaglobulinemia (HP:0004432) | 5.07226083 |
| 3 | Thrombocytosis (HP:0001894) | 4.32112470 |
| 4 | Hepatocellular necrosis (HP:0001404) | 4.28974251 |
| 5 | Abnormality of B cell number (HP:0010975) | 3.99977762 |
| 6 | Increased muscle lipid content (HP:0009058) | 3.95724528 |
| 7 | B lymphocytopenia (HP:0010976) | 3.89699224 |
| 8 | Increased intramyocellular lipid droplets (HP:0012240) | 3.89538069 |
| 9 | Hepatic necrosis (HP:0002605) | 3.76092078 |
| 10 | Increased IgE level (HP:0003212) | 3.70903768 |
| 11 | Microvesicular hepatic steatosis (HP:0001414) | 3.69883937 |
| 12 | Severe combined immunodeficiency (HP:0004430) | 3.54650932 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.46255090 |
| 14 | Autoimmune hemolytic anemia (HP:0001890) | 3.38260503 |
| 15 | Myositis (HP:0100614) | 3.31407500 |
| 16 | Stomatitis (HP:0010280) | 3.29903957 |
| 17 | Acute lymphatic leukemia (HP:0006721) | 3.24538657 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19567414 |
| 19 | Obstructive lung disease (HP:0006536) | 3.19567414 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.16202973 |
| 21 | Cellulitis (HP:0100658) | 3.11588726 |
| 22 | Mitochondrial inheritance (HP:0001427) | 3.06672830 |
| 23 | Type I transferrin isoform profile (HP:0003642) | 3.04159718 |
| 24 | Granulocytopenia (HP:0001913) | 2.98337748 |
| 25 | Hypergammaglobulinemia (HP:0010702) | 2.94514840 |
| 26 | Muscle stiffness (HP:0003552) | 2.90684905 |
| 27 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.89464541 |
| 28 | Dicarboxylic aciduria (HP:0003215) | 2.89464541 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 2.87476504 |
| 30 | Ragged-red muscle fibers (HP:0003200) | 2.82166609 |
| 31 | Rhabdomyolysis (HP:0003201) | 2.81536489 |
| 32 | Hypertensive crisis (HP:0100735) | 2.79919109 |
| 33 | Thoracic kyphosis (HP:0002942) | 2.75321940 |
| 34 | Combined immunodeficiency (HP:0005387) | 2.72658498 |
| 35 | Meningitis (HP:0001287) | 2.72401038 |
| 36 | Recurrent fungal infections (HP:0002841) | 2.66737083 |
| 37 | Recurrent viral infections (HP:0004429) | 2.65233085 |
| 38 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.58987034 |
| 39 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.58987034 |
| 40 | Abnormal protein glycosylation (HP:0012346) | 2.58987034 |
| 41 | Abnormal glycosylation (HP:0012345) | 2.58987034 |
| 42 | Reduced antithrombin III activity (HP:0001976) | 2.57945528 |
| 43 | Seborrheic dermatitis (HP:0001051) | 2.56431387 |
| 44 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.53948393 |
| 45 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.51430287 |
| 46 | Mesangial abnormality (HP:0001966) | 2.44871150 |
| 47 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.43913079 |
| 48 | Metaphyseal dysplasia (HP:0100255) | 2.43401340 |
| 49 | Recurrent abscess formation (HP:0002722) | 2.42925243 |
| 50 | Acute hepatic failure (HP:0006554) | 2.42015806 |
| 51 | Increased IgM level (HP:0003496) | 2.41418471 |
| 52 | Increased CSF lactate (HP:0002490) | 2.40902713 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.39953803 |
| 54 | Urticaria (HP:0001025) | 2.39634636 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.35544425 |
| 56 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.31910883 |
| 57 | Gliosis (HP:0002171) | 2.31713466 |
| 58 | J-shaped sella turcica (HP:0002680) | 2.27610213 |
| 59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.26501337 |
| 60 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.24469308 |
| 61 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.24469308 |
| 62 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.24213779 |
| 63 | Exercise-induced myalgia (HP:0003738) | 2.19327780 |
| 64 | Epistaxis (HP:0000421) | 2.17454206 |
| 65 | Petechiae (HP:0000967) | 2.14032457 |
| 66 | Lipid accumulation in hepatocytes (HP:0006561) | 2.13581317 |
| 67 | IgM deficiency (HP:0002850) | 2.09708567 |
| 68 | Emotional lability (HP:0000712) | 2.09409860 |
| 69 | Reticulocytopenia (HP:0001896) | 2.07979109 |
| 70 | Encephalitis (HP:0002383) | 2.07840096 |
| 71 | Chronic otitis media (HP:0000389) | 2.07790841 |
| 72 | Sepsis (HP:0100806) | 2.02558049 |
| 73 | Skin rash (HP:0000988) | 2.00364040 |
| 74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00040325 |
| 75 | Abnormality of the prostate (HP:0008775) | 2.00007892 |
| 76 | Episodic fever (HP:0001954) | 1.99486453 |
| 77 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.95297027 |
| 78 | Aplastic anemia (HP:0001915) | 1.93254655 |
| 79 | Renal Fanconi syndrome (HP:0001994) | 1.90751935 |
| 80 | Asplenia (HP:0001746) | 1.90578336 |
| 81 | Cerebral palsy (HP:0100021) | 1.90271654 |
| 82 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87045848 |
| 83 | Increased serum lactate (HP:0002151) | 1.85326401 |
| 84 | Exercise intolerance (HP:0003546) | 1.85156136 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 1.84859376 |
| 86 | Lactic acidosis (HP:0003128) | 1.84767755 |
| 87 | Decreased central vision (HP:0007663) | 1.81713149 |
| 88 | Increased hepatocellular lipid droplets (HP:0006565) | 1.81497063 |
| 89 | Erythema (HP:0010783) | 1.78155322 |
| 90 | Amelogenesis imperfecta (HP:0000705) | 1.75634839 |
| 91 | Fatigue (HP:0012378) | 1.75283313 |
| 92 | Pancytopenia (HP:0001876) | 1.75044241 |
| 93 | Myoglobinuria (HP:0002913) | 1.74996482 |
| 94 | Chest pain (HP:0100749) | 1.74606544 |
| 95 | Abnormality of the thoracic spine (HP:0100711) | 1.74367367 |
| 96 | Neoplasm of head and neck (HP:0012288) | 1.74204534 |
| 97 | Esophageal neoplasm (HP:0100751) | 1.74204534 |
| 98 | Abnormality of T cell physiology (HP:0011840) | 1.73271464 |
| 99 | Progressive microcephaly (HP:0000253) | 1.72831235 |
| 100 | Abnormal pupillary function (HP:0007686) | 1.71680495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.27399236 |
| 2 | KIT | 4.20347164 |
| 3 | MAP4K1 | 4.08647245 |
| 4 | VRK2 | 3.98031954 |
| 5 | SCYL2 | 3.91649540 |
| 6 | MAP3K11 | 3.48349427 |
| 7 | FLT3 | 3.44339091 |
| 8 | KDR | 3.03379037 |
| 9 | BCKDK | 2.88889579 |
| 10 | TESK2 | 2.76058198 |
| 11 | ERN1 | 2.67787244 |
| 12 | NME2 | 2.40199843 |
| 13 | TAOK2 | 2.01288874 |
| 14 | GRK6 | 1.99285725 |
| 15 | NUAK1 | 1.98033483 |
| 16 | TBK1 | 1.89542670 |
| 17 | CDC7 | 1.89036592 |
| 18 | PIM2 | 1.79405390 |
| 19 | CSF1R | 1.76136540 |
| 20 | PBK | 1.54866742 |
| 21 | MAP4K2 | 1.43250642 |
| 22 | DAPK1 | 1.42057347 |
| 23 | MAP3K13 | 1.33282671 |
| 24 | MAP2K3 | 1.31939588 |
| 25 | FES | 1.29048316 |
| 26 | TNK2 | 1.28296593 |
| 27 | DYRK1B | 1.21347830 |
| 28 | IKBKE | 1.17853790 |
| 29 | JAK3 | 1.17764622 |
| 30 | SYK | 1.13704888 |
| 31 | PRKD2 | 1.06290968 |
| 32 | BTK | 1.05858961 |
| 33 | ARAF | 1.05795055 |
| 34 | MAP2K2 | 1.02491482 |
| 35 | VRK1 | 1.01512101 |
| 36 | MAPKAPK3 | 0.94995615 |
| 37 | MAP3K5 | 0.90313987 |
| 38 | IKBKB | 0.88183467 |
| 39 | TIE1 | 0.88007520 |
| 40 | ATR | 0.84821988 |
| 41 | TESK1 | 0.84758467 |
| 42 | CDK7 | 0.83937174 |
| 43 | TEC | 0.83393538 |
| 44 | ABL2 | 0.82192605 |
| 45 | CCNB1 | 0.81394190 |
| 46 | MAP3K14 | 0.78268003 |
| 47 | MAP3K7 | 0.77419830 |
| 48 | PRPF4B | 0.77385592 |
| 49 | TAOK1 | 0.76463518 |
| 50 | LCK | 0.75082536 |
| 51 | RPS6KB2 | 0.74212073 |
| 52 | TXK | 0.69583947 |
| 53 | MATK | 0.69447057 |
| 54 | TYK2 | 0.68967820 |
| 55 | PIM1 | 0.64659217 |
| 56 | CDK8 | 0.63918351 |
| 57 | TAF1 | 0.62239672 |
| 58 | PIK3CG | 0.61364203 |
| 59 | CDK9 | 0.61215829 |
| 60 | LRRK2 | 0.60767733 |
| 61 | LYN | 0.56683708 |
| 62 | PKN1 | 0.54897576 |
| 63 | RPS6KA5 | 0.54583644 |
| 64 | GRK5 | 0.54436901 |
| 65 | RPS6KA4 | 0.53275941 |
| 66 | MAP3K1 | 0.50764478 |
| 67 | AURKA | 0.46107802 |
| 68 | PRKD1 | 0.45761230 |
| 69 | NME1 | 0.45390308 |
| 70 | PRKCQ | 0.43670651 |
| 71 | GRK7 | 0.43574637 |
| 72 | ZAK | 0.41365721 |
| 73 | RPS6KA6 | 0.36931531 |
| 74 | CHEK2 | 0.34239487 |
| 75 | RPS6KL1 | 0.33700829 |
| 76 | RPS6KC1 | 0.33700829 |
| 77 | CSNK2A2 | 0.33579658 |
| 78 | CDK19 | 0.32424565 |
| 79 | ITK | 0.30652728 |
| 80 | ADRBK2 | 0.29974839 |
| 81 | AKT2 | 0.29369157 |
| 82 | PRKCD | 0.29340811 |
| 83 | MAPK4 | 0.28536143 |
| 84 | MAPK3 | 0.28473086 |
| 85 | CSNK1G3 | 0.27716263 |
| 86 | RAF1 | 0.27235059 |
| 87 | CDK2 | 0.26970564 |
| 88 | DYRK1A | 0.26946999 |
| 89 | MAPK11 | 0.26928877 |
| 90 | SMG1 | 0.26358056 |
| 91 | CAMK1 | 0.25251328 |
| 92 | CSNK2A1 | 0.25143924 |
| 93 | STK38 | 0.24760534 |
| 94 | PRKCA | 0.24233382 |
| 95 | DYRK3 | 0.23747630 |
| 96 | HIPK2 | 0.23682748 |
| 97 | ADRBK1 | 0.22912498 |
| 98 | DYRK2 | 0.21846073 |
| 99 | JAK2 | 0.20987072 |
| 100 | ATM | 0.20717740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Base excision repair_Homo sapiens_hsa03410 | 4.22621268 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.90858393 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.78729178 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.52335423 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.51888398 |
| 6 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.39271536 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.31248940 |
| 8 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.21513117 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17186027 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.15306182 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.10850607 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.05251494 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.03552758 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.86386039 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.86197634 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.85751596 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81957630 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81792922 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.81574171 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.68496894 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.58811504 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58449372 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.52126200 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50960045 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.47521930 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45802394 |
| 27 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.45245712 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44344468 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43096376 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41291261 |
| 31 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.39189697 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.35482102 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34474525 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.26526896 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.24886526 |
| 36 | Spliceosome_Homo sapiens_hsa03040 | 1.24604746 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.23751890 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22257545 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21122123 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.18554620 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.16754096 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14467284 |
| 43 | Proteasome_Homo sapiens_hsa03050 | 1.10509577 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10407681 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.07265482 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05514107 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.02549223 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99988945 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99964786 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96695449 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96000327 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92475907 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91755793 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.88268516 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86134745 |
| 56 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.85639270 |
| 57 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82431791 |
| 58 | Huntingtons disease_Homo sapiens_hsa05016 | 0.79381058 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.79275835 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78965742 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73543756 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70860428 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68970963 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68837162 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.68796980 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.66769134 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66542949 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63690127 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62959521 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62845911 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62295258 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56807327 |
| 73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54494154 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.54018274 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51395292 |
| 76 | Tuberculosis_Homo sapiens_hsa05152 | 0.49696063 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47083503 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47032313 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46852433 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45778546 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43459260 |
| 82 | Influenza A_Homo sapiens_hsa05164 | 0.43234780 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40259804 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39875693 |
| 85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38614380 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.38549769 |
| 87 | Phototransduction_Homo sapiens_hsa04744 | 0.38513072 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.37147847 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37090490 |
| 90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36367458 |
| 91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35044647 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33708028 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33369286 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.29809398 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.27331350 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27060071 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.26639711 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.26510478 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.26350835 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.24822743 |

